Inhibikase Therapeutics - 53 Year Dividend History | IKT

Historical dividend payout and yield for Inhibikase Therapeutics (IKT) since 1971. The current TTM dividend payout for Inhibikase Therapeutics (IKT) as of December 20, 2024 is $0.00. The current dividend yield for Inhibikase Therapeutics as of December 20, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.212B $0.000B
Inhibikase Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing therapeutics for Parkinson's disease and related disorders. The company operates principally in Boston, Massachusetts. Inhibikase Therapeutics Inc. is headquartered in Atlanta, Georgia.
Stock Name Country Market Cap PE Ratio